Related references
Note: Only part of the references are listed.Design, synthesis, and biological evaluation of novel morpholinated isatin-quinoline hybrids as potent anti-breast cancer agents
Atamjit Singh et al.
ARCHIV DER PHARMAZIE (2022)
Synthesis and Biological Evaluation of 5-benzyl-3-pyridyl-1H-1,2,4-triazole Derivatives as Xanthine Oxidase Inhibitors
Song-Ye Li et al.
MEDICINAL CHEMISTRY (2020)
Thiazole-5-carboxylic acid derivatives as potent xanthine oxidase inhibitors: design, synthesis, in vitro evaluation, and molecular modeling studies
Gurinder Kaur et al.
MEDICINAL CHEMISTRY RESEARCH (2020)
New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation
Atamjit Singh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Design, synthesis and biological evaluation of novel indolinedione-coumarin hybrids as xanthine oxidase inhibitors
Harmandeep Kaur Gulati et al.
MEDICINAL CHEMISTRY RESEARCH (2020)
Effects of Allopurinol on the Progression of Chronic Kidney Disease
Sunil V. Badve et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase
Maria Giulia Battelli et al.
REDOX BIOLOGY (2019)
Cardiovascular disease and uric acid: is the not-so-innocent bystander becoming a true culprit and does the US black box warning for febuxostat indicate that not all uric acid lowering is beneficial?
Franz H. Messerli et al.
EUROPEAN HEART JOURNAL (2019)
Design, Synthesis, Antimicrobial Evaluation, and Molecular Modeling Studies of Novel Indolinedione-Coumarin Molecular Hybrids
Kavita Bhagat et al.
ACS OMEGA (2019)
Monocarbonyl Curcumin-Based Molecular Hybrids as Potent Antibacterial Agents
Atamjit Singh et al.
ACS OMEGA (2019)
Gout and cardiovascular disease: crystallized confusion
Aryeh M. Abeles et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
Design, synthesis and biological evaluation of N-(3-(1H-tetrazol-1-yl)phenyl)isonicotinamide derivatives as novel xanthine oxidase inhibitors
Ting-jian Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Benzoflavone derivatives as potent antihyperuricemic agents
Jatinder V. Singh et al.
MEDCHEMCOMM (2019)
Toward an Understanding of Structural Insights of Xanthine and Aldehyde Oxidases: An Overview of their Inhibitors and Role in Various Diseases
Raj Kumar et al.
MEDICINAL RESEARCH REVIEWS (2018)
Antigout Effects of Plantago asiatica: Xanthine Oxidase Inhibitory Activities Assessed by Electrochemical Biosensing Method
Jin-Xiang Zeng et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)
2016 updated EULAR evidence-based recommendations for the management of gout
P. Richette et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Synthesis, screening and docking of fused pyrano[3,2-d]pyrimidine derivatives as xanthine oxidase inhibitor
Manroopraj Kaur et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Xanthine oxidoreductase in cancer: more than adifferentiation marker
Maria Giulia Battelli et al.
CANCER MEDICINE (2016)
Xanthine Oxidoreductase-Derived Reactive Species: Physiological and Pathological Effects
Maria Giulia Battelli et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Xanthine oxidase inhibitory properties and anti-inflammatory activity of 2-amino-5-alkylidene-thiazol-4-ones
Zaklina Smelcerovic et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
Design, synthesis and evaluation of 2,4-diarylpyrano[3,2-c]chromen-5(4H)-one as a new class of non-purine xanthine oxidase inhibitors
Harpreet S. Virdi et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
Screening of a library of 4-aryl/heteroaryl-4H-fused pyrans for xanthine oxidase inhibition: synthesis, biological evaluation and docking studies
Ramandeep Kaur et al.
MEDICINAL CHEMISTRY RESEARCH (2015)
A Review of Uric Acid, Crystal Deposition Disease, and Gout
Fernando Perez-Ruiz et al.
ADVANCES IN THERAPY (2015)
4,6-Diaryl/heteroarylpyrimidin-2(1H)-ones as a New Class of Xanthine Oxidase Inhibitors
Shiwani Shukla et al.
ARCHIV DER PHARMAZIE (2014)
Synthesis and evaluation of naphthoflavones as a new class of non purine xanthine oxidase inhibitors
Harbinder Singh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Microwave assisted synthesis of naphthopyrans catalysed by silica supported fluoroboric acid as a new class of non purine xanthine oxidase inhibitors
Sahil Sharma et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Design and Synthesis of Aza-Flavones as a New Class of Xanthine Oxidase Inhibitors
Rajni Dhiman et al.
ARCHIV DER PHARMAZIE (2013)
Contribution of uric acid to cancer risk, recurrence, and mortality
Mehdi A. Fini et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2012)
Hydrogen peroxide is the major oxidant product of xanthine oxidase
Eric E. Kelley et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Discovery of 3-(3-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051-a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia
Takahiro Sato et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
An extremely potent inhibitor of xanthine oxidoreductase - Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition
K Okamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The physiology of endothelial xanthine oxidase: From urate catabolism to reperfusion injury to inflammatory signal transduction
A Meneshian et al.
MICROCIRCULATION (2002)
Xanthine oxidase is involved in free radical production in type 1 diabetes -: Protection by allopurinol
MC Desco et al.
DIABETES (2002)
Share Paper
